Hydrogen(H2) treatment for acute erythymatous skin diseases. A report of 4 patients with safety data and a non-controlled feasibility study with H2 concentration measurement on two volunteers
Open Access
- 1 January 2012
- journal article
- Published by Springer Nature in Medical Gas Research
- Vol. 2 (1) , 14
Abstract
We have treated 4 patients of acute erythematous skin diseases with fever and/or pain by H2 enriched intravenous fluid. We also added data from two volunteers for assessing the mode of H2 delivery to the skin for evaluation of feasibility of H2 treatment for this type of skin diseases.Keywords
This publication has 14 references indexed in Scilit:
- Improved brain MRI indices in the acute brain stem infarct sites treated with hydroxyl radical scavengers, Edaravone and hydrogen, as compared to Edaravone alone. A non-controlled studyMedical Gas Research, 2011
- Recent advances in hydrogen research as a therapeutic medical gasFree Radical Research, 2010
- The generalized rash: part I. Differential diagnosis.2010
- Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicalsNature Medicine, 2007
- Edaravone Reduces Early Accumulation of Oxidative Products and Sequential Inflammatory Responses After Transient Focal Ischemia in Mice BrainStroke, 2005
- Association of gp91phox homolog Nox1 with anchorage-independent growth and MAP kinase-activation of transformed human keratinocytesOncogene, 2003
- Inflammatory Skin Diseases, T Cells, and Immune SurveillanceNew England Journal of Medicine, 1999
- Skin Inflammation: Reactive Oxygen Species and the Role of IronJournal of Investigative Dermatology, 1992
- Production and Excretion of Hydrogen Gas in ManNew England Journal of Medicine, 1969
- Measurement of Local Blood Flow with Hydrogen GasCirculation Research, 1964